Eliem Therapeutics Inc

NASDAQ ELYM

Download Data

Eliem Therapeutics Inc Market Capitalization on June 03, 2024: USD 242.62 M

Eliem Therapeutics Inc Market Capitalization is USD 242.62 M on June 03, 2024, a 200.84% change year over year. Market capitalization is a financial metric that represents the total value of a publicly traded company. It is calculated by multiplying the current share price of a company by the total number of outstanding shares. Market capitalization is used to assess the size and relative value of a company in the stock market. It provides investors with an idea of the company's overall worth and is often used as a basis for comparing companies within the same industry or sector. A higher market capitalization generally indicates a larger, more established company.
  • Eliem Therapeutics Inc 52-week high Market Capitalization is USD 282.78 M on May 07, 2024, which is 16.55% above the current Market Capitalization.
  • Eliem Therapeutics Inc 52-week low Market Capitalization is USD 63.97 M on June 23, 2023, which is -73.63% below the current Market Capitalization.
  • Eliem Therapeutics Inc average Market Capitalization for the last 52 weeks is USD 92.12 M.
NASDAQ: ELYM

Eliem Therapeutics Inc

CEO Mr. Robert W. Azelby M.B.A.
IPO Date Aug. 10, 2021
Location United States
Headquarters 23515 NE Novelty Hill Road, Redmond, WA, United States, 98053
Employees 9
Sector Healthcare
Industry Biotechnology
Description

Eliem Therapeutics, Inc., a biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems. The company was incorporated in 2018 and is headquartered in Wilmington, Delaware.

Similar companies

MNOV

MediciNova Inc

USD 1.47

8.09%

ANEB

Anebulo Pharmaceuticals Inc

USD 2.14

4.39%

HCWB

HCW Biologics Inc

USD 1.09

0.00%

AVTE

Aerovate Therapeutics Inc

USD 17.37

-0.46%

ADAG

Adagene Inc

USD 2.67

-4.64%

ACRV

Acrivon Therapeutics Inc. Common Stock

USD 7.70

-0.26%

ANTX

AN2 Therapeutics Inc

USD 2.10

5.53%

CYT

Cyteir Therapeutics Inc

NA

NA

IPSC

Century Therapeutics Inc

USD 2.98

0.34%

StockViz Staff

September 8, 2024

Any question? Send us an email